GLP1ra’s beyond obesity and diabetes: Is the sky the limit?
Glucagon-like peptide-1 receptor agonists (GLP1Ra’s) have taken the type 2 diabetes and obesity market by storm. Outside of the pharmaceutical…
Glucagon-like peptide-1 receptor agonists (GLP1Ra’s) have taken the type 2 diabetes and obesity market by storm. Outside of the pharmaceutical…
Decentralised clinical trials (DCTs) are often pinned as a silver bullet to increase a trial’s footprint and reach various populations…
Academic institutions and commercial entities play an important role in drug development and improving human health. While both types of…
The role of decentralised clinical trials (DCTs) in the clinical trial industry has shifted over the past few years. Moreover,…
More bills that restrict the LGBTQ+ community were passed in the US in 2022. Some of these bills make gender-affirming…
Decades ago, regulators and clinical researchers deemed randomised controlled trials (RCTs) as the “gold standard” in clinical research, in a…
After peaking during the Covid-19 pandemic, the clinical trial industry is re-evaluating the pros and cons of decentralised clinical trials…
One year has passed since Russia rolled its tanks into neighbouring Ukraine. The conflict accounts for the sobering toll of…
In its latest update, Clinical Trials Arena’s decentralised clinical trial (DCT) Adoption Tracker examines DCT activity in 2022 and reveals…
As we count down to the end of 2022, we look at the sponsors, CROs, and sites that were at…